Recall events
/
Event 84527
Event summary
Timeline bucket December 18, 2019
Product types Drug
Classifications Class II
Statuses Terminated
Recalling firm wording MPRX, Inc. dba Medical Park Pharmacy
Dossier provenance
Source snapshots represented here
openFDA Drug Enforcement
Report-date coverage
June 20, 2012–July 08, 2026
Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.
Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.
How coverage and grouping work
Device root-cause evidence is not applicable to this event.
No grouped product has the official product type device; this is not an unavailable-enrichment finding.
Complete imported group
Every recalled product in this event
18 official enforcement rows
Product dates, classifications, firms, and source wording remain attached to their individual rows.
Opening this dossier never hides products that did not match a prior timeline filter.
drug · product 1 of 18
DHEA/Pregnenol One 10.25 MG Cap
D-0803-2020
Recall number D-0803-2020
Initiated December 18, 2019
Classification Class II
Status Terminated
Quantity 1 bottle
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
Labeling: Incorrect or missing
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Incorrect or missing lot and/or expiration date. Products were compounded using expired components.
Code information Lot: L61406:42 Use by: 05/06/2020
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[11748]
FDA event record
· Exact recall-number query on openFDA
drug · product 2 of 18
Finasteride/Biotin 1 mg/50 mcg
D-0804-2020
Recall number D-0804-2020
Initiated December 18, 2019
Classification Class II
Status Terminated
Quantity 1 bottle
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
Labeling: Incorrect or missing
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Incorrect or missing lot and/or expiration date. Products were compounded using expired components.
Code information Lot: 60658:42 Use by: 12/28/2019
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[11944]
FDA event record
· Exact recall-number query on openFDA
drug · product 3 of 18
Lidocaine/Priloc/PE 15/5/0.25% 30 GM jars
D-0805-2020
Recall number D-0805-2020
Initiated December 18, 2019
Classification Class II
Status Terminated
Quantity 2 jars
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
Labeling: Incorrect or missing
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Incorrect or missing lot and/or expiration date. Products were compounded using expired components.
Code information Lot: 61367:42 Use by: 04/28/2020
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[11942]
FDA event record
· Exact recall-number query on openFDA
drug · product 4 of 18
Lidocaine/Priloc/PE 30/5/0.25% 30 GM jars
D-0806-2020
Recall number D-0806-2020
Initiated December 18, 2019
Classification Class II
Status Terminated
Quantity 12 jars
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
Labeling: Incorrect or missing
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Incorrect or missing lot and/or expiration date. Products were compounded using expired components.
Code information Lots: 61134:42 Use by: 01/31/2020; 61302:26 Use by: 04/14/2020; 61318:42 Use by: 04/19/2020
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[11974]
FDA event record
· Exact recall-number query on openFDA
drug · product 5 of 18
Liothyronine (T3) 80 mcg SR cap
D-0807-2020
Recall number D-0807-2020
Initiated December 18, 2019
Classification Class II
Status Terminated
Quantity 5 bottles
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
Labeling: Incorrect or missing
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Incorrect or missing lot and/or expiration date. Products were compounded using expired components.
Code information Lot: 61253:42 Use by: 04/01/2020
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[11758]
FDA event record
· Exact recall-number query on openFDA
drug · product 6 of 18
Liothyronine (T3) 92.5 MCG
D-0808-2020
Recall number D-0808-2020
Initiated December 18, 2019
Classification Class II
Status Terminated
Quantity 4 bottles
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
Labeling: Incorrect or missing
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Incorrect or missing lot and/or expiration date. Products were compounded using expired components.
Code information Lot: 61024:99 Use by: 02/20/2020
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[11996]
FDA event record
· Exact recall-number query on openFDA
drug · product 7 of 18
Magic Bullet Supplement
D-0809-2020
Recall number D-0809-2020
Initiated December 18, 2019
Classification Class II
Status Terminated
Quantity 1 bottles
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
Labeling: Incorrect or missing
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Incorrect or missing lot and/or expiration date. Products were compounded using expired components.
Code information Lot: 61048:99 Use by: 02/08/2020
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[11730]
FDA event record
· Exact recall-number query on openFDA
drug · product 8 of 18
Naltrexone 4.5 mg capsule
D-0810-2020
Recall number D-0810-2020
Initiated December 18, 2019
Classification Class II
Status Terminated
Quantity 2 bottles
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
Labeling: Incorrect or missing
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Incorrect or missing lot and/or expiration date. Products were compounded using expired components.
Code information Lot: 60564:42 Use by: 02/10/2020
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[11968]
FDA event record
· Exact recall-number query on openFDA
drug · product 9 of 18
Progesterone 200 mg Troche
D-0811-2020
Recall number D-0811-2020
Initiated December 18, 2019
Classification Class II
Status Terminated
Quantity 1 bottle
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
Labeling: Incorrect or missing
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Incorrect or missing lot and/or expiration date. Products were compounded using expired components.
Code information Lot: 61242:26 Use by: 02/28/2020
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[11898]
FDA event record
· Exact recall-number query on openFDA
drug · product 10 of 18
Progesterone 50 mg capsules
D-0812-2020
Recall number D-0812-2020
Initiated December 18, 2019
Classification Class II
Status Terminated
Quantity 1 bottle
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
Labeling: Incorrect or missing
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Incorrect or missing lot and/or expiration date. Products were compounded using expired components.
Code information Lot: 61215:26 Use by: 03/23/2020
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[11955]
FDA event record
· Exact recall-number query on openFDA
drug · product 11 of 18
Progesterone E4M SR 100 mg capsules
D-0813-2020
Recall number D-0813-2020
Initiated December 18, 2019
Classification Class II
Status Terminated
Quantity 3 bottles
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
Labeling: Incorrect or missing
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Incorrect or missing lot and/or expiration date. Products were compounded using expired components.
Code information Lot: 61219:42 Use by: 03/24/2020
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[11984]
FDA event record
· Exact recall-number query on openFDA
drug · product 12 of 18
Sildenafil 200 mg Troche (Clinic)
D-0814-2020
Recall number D-0814-2020
Initiated December 18, 2019
Classification Class II
Status Terminated
Quantity 1 bottle
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
Labeling: Incorrect or missing
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Incorrect or missing lot and/or expiration date. Products were compounded using expired components.
Code information Lot: 61392:42 Use by: 05/05/2020
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[11952]
FDA event record
· Exact recall-number query on openFDA
drug · product 13 of 18
Sildenafil 80 mg capsules
D-0815-2020
Recall number D-0815-2020
Initiated December 18, 2019
Classification Class II
Status Terminated
Quantity 1 bottle
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
Labeling: Incorrect or missing
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Incorrect or missing lot and/or expiration date. Products were compounded using expired components.
Code information Lot: 61404:42 Use by: 05/06/2020
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[11698]
FDA event record
· Exact recall-number query on openFDA
drug · product 14 of 18
Squaric Acid 0.1% Topical Solution (Clinic) 30 mL
D-0816-2020
Recall number D-0816-2020
Initiated December 18, 2019
Classification Class II
Status Terminated
Quantity 1 bottle
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
Labeling: Incorrect or missing
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Incorrect or missing lot and/or expiration date. Products were compounded using expired components.
Code information Lot: 61380:42 Use by: 05/04/2020
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[11685]
FDA event record
· Exact recall-number query on openFDA
drug · product 15 of 18
T3/T4 SR 9 mcg/38 mcg capsule
D-0817-2020
Recall number D-0817-2020
Initiated December 18, 2019
Classification Class II
Status Terminated
Quantity 2 bottles
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
Labeling: Incorrect or missing
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Incorrect or missing lot and/or expiration date. Products were compounded using expired components.
Code information Lot: 61296:42Use by: 04/13/2020
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[11966]
FDA event record
· Exact recall-number query on openFDA
drug · product 16 of 18
Tadalafil 20 mg Troche
D-0818-2020
Recall number D-0818-2020
Initiated December 18, 2019
Classification Class II
Status Terminated
Quantity 9 bottles
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
Labeling: Incorrect or missing
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Incorrect or missing lot and/or expiration date. Products were compounded using expired components.
Code information Lots: 61137:42 Use by: 03/08/2020; 61324:99 Use by: 04/04/2020; 60856:42 Use by: 02/02/2020
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[11902]
FDA event record
· Exact recall-number query on openFDA
drug · product 17 of 18
Tadalafil 6 mg Capsule
D-0819-2020
Recall number D-0819-2020
Initiated December 18, 2019
Classification Class II
Status Terminated
Quantity 7 bottles
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
Labeling: Incorrect or missing
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Incorrect or missing lot and/or expiration date. Products were compounded using expired components.
Code information Lots: 61229:26 Use by: 03/25/2020; 61229:42 Use by: 03/25/2020
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[11967]
FDA event record
· Exact recall-number query on openFDA
drug · product 18 of 18
Testosterone Topical Cream 4%
D-0820-2020
Recall number D-0820-2020
Initiated December 18, 2019
Classification Class II
Status Terminated
Quantity 3 bottles
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
Labeling: Incorrect or missing
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Incorrect or missing lot and/or expiration date. Products were compounded using expired components.
Code information Lot: 61463:42 Use by: 02/27/2020
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[11986]
FDA event record
· Exact recall-number query on openFDA
